Edgewise Therapeutics, Inc.EWTXNASDAQ
Loading
EBITDA Over TimeContracting
Percentile Rank0
Studio
Year-over-Year Change

Earnings before interest, taxes, depreciation, and amortization

Latest
$-165.53M
↓ 101% vs avg
Percentile
P0
Near historical low
Streak
6 yr
Consecutive declineContracting
Average
$-82.22M
Historical baseline
PeriodValueYoY Change
2025$-165.53M-5.7%
2024$-156.54M-39.0%
2023$-112.63M-58.4%
2022$-71.12M-65.6%
2021$-42.94M-152.5%
2020$-17.01M-73.5%
2019$-9.80M-